Optimization of Percutaneous Coronary Intervention: Is There a Place for Physiology?
- PMID: 37821186
- DOI: 10.1016/j.jcin.2023.09.002
Optimization of Percutaneous Coronary Intervention: Is There a Place for Physiology?
Keywords: coronary artery disease; percutaneous coronary intervention; post-PCI fractional flow reserve; stent optimization; target vessel failure.
Conflict of interest statement
Funding Support and Author Disclosures Dr Räber has received institutional research grants from Abbott, Biotronik, Boston Scientific, HeartFlow, Infraredx, Swiss National Science Foundation, Swiss Heart Foundation, Sanofi, and Regeneron; and speaker/consultant fees from Abbott, Amgen, AstraZeneca, Canon, Novo Nordisk, Medtronic, Merck, Occlutech, Sanofi, and Vifor. Dr Biccirè has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Impact of Post-PCI FFR Stratified by Coronary Artery.JACC Cardiovasc Interv. 2023 Oct 9;16(19):2396-2408. doi: 10.1016/j.jcin.2023.08.018. JACC Cardiovasc Interv. 2023. PMID: 37821185
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources